Top
image credit: Adobe Stock

3 Predictions for Post-COVID Clinical Trial Decentralization

April 27, 2022

Category:

Prior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down.

Survey data from WCG Avoca shows that research sites and sponsors expect 89% of clinical trials to qualify as a hybrid, with a mix of decentralized technology and in-person visits.

Read More on HitConsultant